Caribou Biosciences Inc. (CRBU) Gets a Nice Early Win - RBC Capital
Tweet Send to a Friend
RBC Capital analyst Luca Issi reiterated an Outperform rating and $22.00 price target on Caribou Biosciences Inc. (NASDAQ: CRBU) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
